Multitarget deep brain stimulation for epilepsy

Author:

Yang Andrew I.1,Isbaine Faical1,Alwaki Abdulrahman2,Gross Robert E.12

Affiliation:

1. Departments of Neurosurgery and

2. Neurology, Emory University School of Medicine, Atlanta, Georgia

Abstract

OBJECTIVE Deep brain stimulation (DBS) is a rapidly growing surgical option for patients with drug-resistant epilepsy who are not candidates for resective/ablative surgery. Recent randomized controlled trials have demonstrated efficacy of DBS of the anterior nucleus of the thalamus (ANT), particularly in frontal or temporal epilepsy, whereas DBS of the centromedian (CM) nucleus appears to be most suitable in well-defined generalized epilepsy syndromes. At the authors’ institution, DBS candidates who did not fit the populations represented in these trials were managed with DBS of multiple distinct targets, which included ANT, CM, and less-studied nuclei—i.e., mediodorsal nucleus, pulvinar, and subthalamic nucleus. The goal of this study was to present the authors’ experience with these types of cases, and to motivate future investigations that can determine the long-term efficacy of multitarget DBS. METHODS This single-center retrospective study of adult patients with drug-resistant epilepsy who underwent multitarget DBS was performed to demonstrate the feasibility and safety of this approach, and to present seizure outcomes. Patients in this cohort had epilepsy with features that were difficult to treat with DBS of the ANT or CM nucleus alone, including multifocal/multilobar, diffuse-onset, and/or posterior-onset seizures; or both generalized and focal seizures. RESULTS Eight patients underwent DBS of 2–3 distinct thalamic/subthalamic nuclei. DBS was performed with 2 electrodes in each hemisphere. All leads in each patient were implanted with either frontal or parietal trajectories. There were no surgical complications. Among those with > 6 months of follow-up (n = 5; range 7–21 months), all patients were responders in terms of overall seizure frequency and/or convulsive seizure frequency (i.e., ≥ 50% reduction). Two patients had adverse stimulation effects, which resolved with further programming. CONCLUSIONS Multitarget DBS is a procedurally feasible and safe treatment strategy to maximize outcomes in patients with complex epilepsy. The authors highlight their approach to inform future studies that are sufficiently powered to assess its efficacy.

Publisher

Journal of Neurosurgery Publishing Group (JNSPG)

Subject

Genetics,Animal Science and Zoology

Reference31 articles.

1. The SANTÉ study at 10 years of follow-up: effectiveness, safety, and sudden unexpected death in epilepsy;Salanova V,2021

2. Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy;Fisher R,2010

3. Deep brain stimulation of the centromedian thalamic nucleus for the treatment of generalized and frontal epilepsies;Valentín A,2013

4. Placebo-controlled pilot study of centromedian thalamic stimulation in treatment of intractable seizures;Fisher RS,1992

5. Predictors in the treatment of difficult-to-control seizures by electrical stimulation of the centromedian thalamic nucleus;Velasco F,2000

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3